Skip to content
zameds

Dexamethasone, lidocaine, neomycin, polymyxin b, sulfiram (Otospectrine Eardrops)

Dexamethasone, lidocaine, neomycin, polymyxin b, sulfiram

Phenix SA (Pty) Ltd

Registration

Applicant
Phenix SA (Pty) Ltd
Registrations
1

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Otospectrine eardrops

EACH 1 ml SUSPENSION CONTAINS DEXAMETHASONE A 1 mg LIDOCAINE HYDROCHLORIDE A 40 mg NEOMYCIN SULPHATE A 5 000 IU POLYMYXIN B SULFATE A 10 000 IU SULFIRAM A 50 mg

Not listed83/287Old MedicineNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles